Gene therapy trial launched for X-linked retinitis pigmentosa – ModernMedicine
|
Gene therapy trial launched for X-linked retinitis pigmentosa
ModernMedicine Researchers have injected their first patient with a virus engineered to remodel the gene responsible for X-linked retinitis pigmentosa (XLRP). “If successful, this gene therapy has the potential to transform the lives of many patients,” said David … |
|
Gene therapy trial launched for X-linked retinitis pigmentosa
ModernMedicine Researchers have injected their first patient with a virus engineered to remodel the gene responsible for X-linked retinitis pigmentosa (XLRP). “If successful, this gene therapy has the potential to transform the lives of many patients,” said David … |
|
Stem cell innovation regrows rotator cuffs
EurekAlert (press release) The mesh, made of a nanostructured polymer combining polylactic acid (PCL) and polyphosphazene (PNEAmPh) — pioneered in Laurencin’s laboratory — provides an attractive habitat for the stem cells to hunker down. Once they settle into the rotator cuff … |
Coos Bay World |
Doctors say unproven stem cell treatment blinded 3 women | South …
Coos Bay World NEW YORK (AP) — Three women were left nearly or totally blind by a vision treatment at a stem cell clinic, in what doctors call a dramatic illustration of how. The Shady Business Of Experimental Stem Cell Treatments …Worldcrunch |
GeekWire |
Fred Hutch study: Cancer drug inspired by bacteria could boost immunotherapy treatments
GeekWire Even more importantly, researchers saw signs that the drug could be used to make emerging immunotherapy treatments more effective. The results will be presented Monday at the annual meeting of the American Association for Cancer Research. The study … With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancerFred Hutch News Service |
News-Medical.net |
Researchers discover potential novel strategy for improving immunotherapy against cancer
News-Medical.net “Our data shows that two compounds on a single nanoparticle will make immunotherapy treatments even more effective,” said the study’s senior author Andrew Wang, MD, a UNC Lineberger member and associate professor in the UNC School of Medicine … |